{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T17:33:26Z","timestamp":1768412006458,"version":"3.49.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T00:00:00Z","timestamp":1557446400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s11739-019-02101-8","type":"journal-article","created":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T12:51:25Z","timestamp":1557492685000},"page":"1271-1278","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["High-dose lormetazepam dependence: strange case of Dr. Jekyll and Mr. Hyde"],"prefix":"10.1007","volume":"14","author":[{"given":"Marco","family":"Faccini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1561-2187","authenticated-orcid":false,"given":"Stefano","family":"Tamburin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Casari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Morbioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Lugoboni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,10]]},"reference":[{"key":"2101_CR1","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1111\/j.1360-0443.2011.03563.x","volume":"106","author":"M Lader","year":"2011","unstructured":"Lader M (2011) Benzodiazepines revisited-will we ever learn? Addiction 106:2086\u20132109","journal-title":"Addiction"},{"key":"2101_CR2","first-page":"1","volume":"112","author":"K Janhsen","year":"2015","unstructured":"Janhsen K, Roser P, Hoffmann K (2015) The problems of long-term treatment with benzodiazepines and related substances. Prescribing practice, epidemiology and the treatment of withdrawal. Dtsch Arztebl Int 112:1\u20137","journal-title":"Dtsch Arztebl Int"},{"key":"2101_CR3","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1056\/NEJMra1611832","volume":"376","author":"M Soyka","year":"2017","unstructured":"Soyka M (2017) Treatment of benzodiazepine dependence. N Engl J Med 376:1147\u20131157","journal-title":"N Engl J Med"},{"key":"2101_CR4","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.eurpsy.2015.09.003","volume":"30","author":"TA Kurko","year":"2015","unstructured":"Kurko TA, Saastamoinen LK, T\u00e4hk\u00e4p\u00e4\u00e4 S, Tuulio-Henriksson A, Taiminen T, Tiihonen J, Airaksinen MS, Hietala J (2015) Long-term use of benzodiazepines: definitions, prevalence and usage patterns\u2014a systematic review of register-based studies. Eur Psychiatry 30:1037\u20131047","journal-title":"Eur Psychiatry"},{"key":"2101_CR5","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1177\/0269881116647505","volume":"30","author":"M Faccini","year":"2016","unstructured":"Faccini M, Leone R, Opri S, Casari R, Resentera C, Morbioli L, Conforti A, Lugoboni F (2016) Slow subcutaneous infusion of flumazenil for the treatment of long-term, high-dose benzodiazepine users: a review of 214 cases. J Psychopharmacol 30:1047\u20131053","journal-title":"J Psychopharmacol"},{"key":"2101_CR6","doi-asserted-by":"crossref","first-page":"e0142057","DOI":"10.1371\/journal.pone.0142057","volume":"10","author":"M Liebrenz","year":"2015","unstructured":"Liebrenz M, Schneider M, Buadze A, Gehring MT, Dube A, Caflisch C (2015) High-dose benzodiazepine dependence: a qualitative study of patients' perceptions on initiation, reasons for use, and obtainment. PLoS ONE 10:e0142057","journal-title":"PLoS ONE"},{"key":"2101_CR7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.drugalcdep.2014.06.020","volume":"142","author":"F Lugoboni","year":"2014","unstructured":"Lugoboni F, Mirijello A, Faccini M, Casari R, Cossari A, Musi G, Bissoli G, Quaglio G, Addolorato G (2014) Quality of life in a cohort of high-dose benzodiazepine dependent patients. Drug Alcohol Depend 142:105\u2013109","journal-title":"Drug Alcohol Depend"},{"key":"2101_CR8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/ijerph14010038","volume":"14","author":"S Tamburin","year":"2017","unstructured":"Tamburin S, Federico A, Faccini M, Casari R, Morbioli L, Sartore V, Mirijello A, Addolorato G, Lugoboni F (2017) Determinants of quality of life in high-dose benzodiazepine misusers. Int J Environ Res Public Health 14:38","journal-title":"Int J Environ Res Public Health"},{"key":"2101_CR9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10072-016-2732-5","volume":"38","author":"A Federico","year":"2017","unstructured":"Federico A, Tamburin S, Maier A, Faccini M, Casari R, Morbioli L, Lugoboni F (2017) Multifocal cognitive dysfunction in high-dose benzodiazepine users: a cross-sectional study. Neurol Sci 38:137\u2013142","journal-title":"Neurol Sci"},{"key":"2101_CR10","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/YIC.0b013e328105e0f2","volume":"22","author":"S Petitjean","year":"2007","unstructured":"Petitjean S, Ladewig D, Meier CR, Amrein R, Wiesbeck GA (2007) Benzodiazepine prescribing to the Swiss adult population: results from a national survey of community pharmacies. Int Clin Psychopharmacol 22:292\u2013298","journal-title":"Int Clin Psychopharmacol"},{"key":"2101_CR11","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1159\/000437201","volume":"84","author":"F Cosci","year":"2015","unstructured":"Cosci F, Guidi J, Balon R, Fava GA (2015) Clinical methodology matters in epidemiology: not all benzodiazepines are the same. Psychother Psychosom 84:262\u2013264","journal-title":"Psychother Psychosom"},{"key":"2101_CR12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000434755","volume":"84","author":"JM Cloos","year":"2015","unstructured":"Cloos JM, Bocquet V, Rolland-Portal I, Koch P, Chouinard G (2015) Hypnotics and triazolobenzodiazepines\u2014best predictors of high-dose benzodiazepine use: results from the Luxembourg National Health Insurance Registry. Psychother Psychosom 84:273\u2013283","journal-title":"Psychother Psychosom"},{"key":"2101_CR13","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1254\/fpj.98.5_399","volume":"98","author":"M Ozawa","year":"1991","unstructured":"Ozawa M, Nakada Y, Sugimachi K, Akai T, Yamaguchi M (1991) Interaction of the hypnotic lormetazepam with central benzodiazepine receptor subtypes omega 1, omega 2 and omega 3. Nihon Yakurigaku Zasshi 98:399\u2013408","journal-title":"Nihon Yakurigaku Zasshi"},{"key":"2101_CR14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0006-8993(02)04082-9","volume":"964","author":"WA Kaufmann","year":"2003","unstructured":"Kaufmann WA, Humpel C, Alheid GF, Marksteiner J (2003) Compartmentation of alpha 1 and alpha 2 GABA(A) receptor subunits within rat extended amygdala: implications for benzodiazepine action. Brain Res 964:91\u201399","journal-title":"Brain Res"},{"key":"2101_CR15","first-page":"1870","volume":"35","author":"L Zecca","year":"1985","unstructured":"Zecca L, Reina L, Scaglione F, Ferrario P, Pirola R, Ceccarelli G, Ciampini M, Fraschini F (1985) Relative bioavailability in humans for oral tablets and solutions of lormetazepam. Arzneimittelforschung 35:1870\u20131872","journal-title":"Arzneimittelforschung"},{"key":"2101_CR16","doi-asserted-by":"crossref","first-page":"859","DOI":"10.2165\/00044011-200222120-00006","volume":"22","author":"P Guerra","year":"2002","unstructured":"Guerra P, Soto A, Carcas AJ, Sancho A, Cassinello A, Frias-Iniesta J (2002) Comparison of lormetazepam solution and capsules in healthy volunteers. early exposure and drug pharmacokinetics. Clin Drug Invest 22:859\u2013866","journal-title":"Clin Drug Invest"},{"key":"2101_CR17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/hup.572","volume":"19","author":"C Ancolio","year":"2004","unstructured":"Ancolio C, Tardieu S, Soubrouillard C, Alquier C, Pradel V, Micallef J, Blin O (2004) A randomized clinical trial comparing doses and efficacy of lormetazepam tablets or oral solution for insomnia in a general practice setting. Hum Psychopharmacol 19:129\u2013134","journal-title":"Hum Psychopharmacol"},{"key":"2101_CR18","first-page":"43","volume":"5","author":"M Faccini","year":"2012","unstructured":"Faccini M, Leone R, Pajusco B, Quaglio G, Casari R, Albiero A, Donati M, Lugoboni F (2012) Lormetazepam addiction: data analysis from an Italian medical unit for addiction. Risk Manag Healthc Policy 5:43\u201348","journal-title":"Risk Manag Healthc Policy"},{"key":"2101_CR19","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1177\/0269881117714050","volume":"31","author":"S Tamburin","year":"2017","unstructured":"Tamburin S, Faccini M, Casari R, Federico A, Morbioli L, Franchini E, Bongiovanni LG, Lugoboni F (2017) Low risk of seizures with slow flumazenil infusion and routine anticonvulsant prophylaxis for high-dose benzodiazepine dependence. J Psychopharmacol 31:1369\u20131373","journal-title":"J Psychopharmacol"},{"key":"2101_CR20","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2000","unstructured":"American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Press, Washington (text revision)","edition":"4"},{"key":"2101_CR21","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9781585623440","volume-title":"The American psychiatric publishing textbook of substance abuse treatment","author":"M Galanter","year":"2008","unstructured":"Galanter M, Kleber HD (2008) The American psychiatric publishing textbook of substance abuse treatment, 4th edn. American Psychiatric Publishers, Arlington","edition":"4"},{"key":"2101_CR22","volume-title":"Structured clinical interview for DSM-IV-TR Axis I disorders, patient edition (SCID-I\/P)","author":"MB First","year":"2002","unstructured":"First MB, Spitzer RL, Gibbon M, Williams JBW (2002) Structured clinical interview for DSM-IV-TR Axis I disorders, patient edition (SCID-I\/P). Biometrics Research, New York State Psychiatric Institute, New York"},{"key":"2101_CR23","volume-title":"The diagnostic interview for DSM-IV personality disorders (DIPD-IV)","author":"M Zanarini","year":"1996","unstructured":"Zanarini M, Frankenburg F, Sickel A, Yong L (1996) The diagnostic interview for DSM-IV personality disorders (DIPD-IV). McLean Hospital, Belmont"},{"key":"2101_CR24","doi-asserted-by":"crossref","DOI":"10.1002\/0471722146","volume-title":"Applied logistic regression","author":"DW Hosmer","year":"2000","unstructured":"Hosmer DW, Lemeshow S (2000) Applied logistic regression, 2nd edn. Wiley, New York","edition":"2"},{"key":"2101_CR25","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/jts.20254","volume":"20","author":"JA Hermos","year":"2007","unstructured":"Hermos JA, Young MM, Lawler EV, Rosenbloom D, Fiore LD (2007) Long-term, high-dose benzodiazepine prescriptions in veteran patients with PTSD: influence of preexisting alcoholism and drug-abuse diagnoses. J Trauma Stress 20:909\u2013914","journal-title":"J Trauma Stress"},{"key":"2101_CR26","unstructured":"Agenzia Italiana del Farmaco (AIFA) (2018) The Medicines Utilisation Monitoring Centre. National Report on Medicines use in Italy. Year 2017. Rome: Italian Medicines Agency. \nhttps:\/\/www.aifa.gov.it\/content\/luso-dei-farmaci-italia-rapporto-osmed-2017\n\n. Accessed 3 Feb 2019."},{"key":"2101_CR27","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4321\/S1135-57272013000300004","volume":"87","author":"MP Vicente-S\u00e1nchez","year":"2013","unstructured":"Vicente-S\u00e1nchez MP, Mac\u00edas-Saint-Gerons D, de la Fuente-Honrubia C, Gonz\u00e1lez-Bermejo D, Montero-Corominas D, Catal\u00e1-L\u00f3pez F (2013) Trends of use of anxiolytics and hypnotics in Spain from 2000 to 2011. Rev Esp Salud Publica 87:247\u2013255","journal-title":"Rev Esp Salud Publica"},{"key":"2101_CR28","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1177\/0269881113503509","volume":"27","author":"DS Baldwin","year":"2013","unstructured":"Baldwin DS, Aitchison K, Bateson A, Curran HV, Davies S, Leonard B, Nutt DJ, Stephens DN, Wilson S (2013) Benzodiazepines: risks and benefits: a reconsideration. J Psychopharmacol 27:967\u2013971","journal-title":"J Psychopharmacol"},{"issue":"11","key":"2101_CR29","first-page":"10","volume":"2013","author":"F Hoffmann","year":"2013","unstructured":"Hoffmann F (2013) Benefits and risks of benzodiazepines and Z-drugs: comparison of perceptions of GPs and community pharmacists in Germany. Ger Med Sci 2013(11):10","journal-title":"Ger Med Sci"},{"key":"2101_CR30","unstructured":"Eudra Vigilance Database (2018) \nhttps:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/regulation\/general\/general_content_000679.jsp\n\n. Accessed 30 Sep 2018"},{"key":"2101_CR31","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nature08758","volume":"463","author":"KR Tan","year":"2010","unstructured":"Tan KR, Brown M, Labou\u00e8be G, Yvon C, Creton C, Fritschy JM, Rudolph U, L\u00fcscher C (2010) Neural bases for addictive properties of benzodiazepines. Nature 463:769\u2013774","journal-title":"Nature"},{"key":"2101_CR32","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.tins.2011.01.004","volume":"34","author":"KR Tan","year":"2011","unstructured":"Tan KR, Rudolph U, Luscher C (2011) Hooked on benzodiazepines: GABAA receptor subtypes and addiction. Trends Neurosci 34:188\u2013197","journal-title":"Trends Neurosci"},{"key":"2101_CR33","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.2147\/NDT.S164307","volume":"14","author":"T Cheng","year":"2018","unstructured":"Cheng T, Wallace DM, Ponteri B, Tuli M (2018) Valium without dependence? Individual GABAA receptor subtype contribution toward benzodiazepine addiction, tolerance, and therapeutic effects. Neuropsychiatr Dis Treat 14:1351\u20131361","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2101_CR34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuroscience.2015.11.021","volume":"313","author":"E Calixto","year":"2016","unstructured":"Calixto E (2016) GABA withdrawal syndrome: GABAA receptor, synapse, neurobiological implications and analogies with other abstinences. Neuroscience 313:57\u201372","journal-title":"Neuroscience"},{"key":"2101_CR35","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.drugalcdep.2009.04.017","volume":"104","author":"SY Fang","year":"2009","unstructured":"Fang SY, Chen CY, Chang IS, Wu EC, Chang CM, Lin KM (2009) Predictors of the incidence and discontinuation of long-term use of benzodiazepines: a population-based study. Drug Alcohol Depend 104:140\u2013146","journal-title":"Drug Alcohol Depend"},{"key":"2101_CR36","unstructured":"Italian Ministry of Health (2017) Alcohol: guide to use. Rome: Italian Ministry of Health. \nhttps:\/\/www.salute.gov.it\/portale\/salute\/p1_5.jsp?lingua=italiano&id=81&area=Vivi_sano\n\n. Accessed 27 Sep 2018"},{"key":"2101_CR37","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.comppsych.2016.06.008","volume":"69","author":"F Cosci","year":"2016","unstructured":"Cosci F, Mansueto G, Faccini M, Casari R, Lugoboni F (2016) Socio-demographic and clinical characteristics of benzodiazepine long-term users: Results from a tertiary care center. Compr Psychiatry 69:211\u2013215","journal-title":"Compr Psychiatry"},{"key":"2101_CR38","first-page":"19","volume":"50","author":"N Magrini","year":"1996","unstructured":"Magrini N, Vaccheri A, Parma E, D'Alessandro R, Bottoni A, Occhionero M, Montanaro N (1996) Use of benzodiazepines in the Italian general population: prevalence, pattern of use and risk factors for use. Clin Pharmacol 50:19\u201325","journal-title":"Clin Pharmacol"},{"key":"2101_CR39","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jamapsychiatry.2014.1763","volume":"72","author":"M Olfson","year":"2015","unstructured":"Olfson M, King M, Schoenbaum M (2015) Benzodiazepine use in the United States. JAMA Psychiatry 72:136\u2013142","journal-title":"JAMA Psychiatry"},{"key":"2101_CR40","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1136\/bmj.307.6900.363","volume":"307","author":"FW Van Der Waals","year":"1993","unstructured":"Van Der Waals FW, Mohrs J, Foets M (1993) Sex differences among recipients of benzodiazepines in Dutch general practice. BMJ 307:363\u2013366","journal-title":"BMJ"},{"key":"2101_CR41","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0163-8343(98)00078-4","volume":"21","author":"A P\u00e9lissolo","year":"1999","unstructured":"P\u00e9lissolo A, Notides C, L\u00e9pine JP, Bisserbe JC (1999) Anxiolytic and hypnotic use by general hospital inpatients: the impact of psychopathology and general medical conditions. Gen Hosp Psychiatry 21:79\u201386","journal-title":"Gen Hosp Psychiatry"},{"key":"2101_CR42","first-page":"38","volume":"29","author":"M Kazim","year":"2015","unstructured":"Kazim M, Abar A, Hanif M, Mansoor S, Tahir S, Mehmood A, Yousafzai AW (2015) Pattern of benzodiazepine prescription in internal medicine outpatients at a tertiary care hospital in Pakistan. Postgrad Med Inst 29:38\u201342","journal-title":"Postgrad Med Inst"},{"key":"2101_CR43","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3109\/13651500903447810","volume":"14","author":"J Donoghue","year":"2010","unstructured":"Donoghue J, Lader M (2010) Usage of benzodiazepines: a review. Psychiatry Clin Pract 14:78\u201387","journal-title":"Psychiatry Clin Pract"},{"key":"2101_CR44","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/ajad.12573","volume":"26","author":"S Tamburin","year":"2017","unstructured":"Tamburin S, Federico A, Morbioli L, Faccini M, Casari R, Zamboni L, Briguglio G, Lugoboni F (2017) Screening for adult attention deficit\/hyperactivity disorder in high-dose benzodiazepine dependent patients. Am J Addict 26:610\u2013614","journal-title":"Am J Addict"},{"key":"2101_CR45","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.drugalcdep.2017.05.014","volume":"178","author":"PL O'Brien","year":"2017","unstructured":"O'Brien PL, Karnell LH, Gokhale M, Kenneth Pack BS, Campopiano M, Zur J (2017) Prescribing of benzodiazepines and opioids to individuals with substance use disorders. Drug Alcohol Depend 178:223\u2013230","journal-title":"Drug Alcohol Depend"},{"key":"2101_CR46","first-page":"589","volume":"126","author":"JG Bramness","year":"2006","unstructured":"Bramness JG, Skurtveit S, Furu K, Engeland A, Sakshaug S, R\u00f8nning M (2006) Changes in sale and use of flunitrazepam in Norway after 1999. Tidsskr Nor Laegeforen 126:589\u2013590","journal-title":"Tidsskr Nor Laegeforen"},{"key":"2101_CR47","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.drugpo.2007.09.006","volume":"20","author":"J Mounteney","year":"2009","unstructured":"Mounteney J, Haugland S (2009) Earlier warning: a multi-indicator approach to monitoring trends in the illicit use of medicines. Int J Drug Policy 20:161\u2013169","journal-title":"Int J Drug Policy"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-019-02101-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11739-019-02101-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-019-02101-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:21:40Z","timestamp":1588965700000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11739-019-02101-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,10]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["2101"],"URL":"https:\/\/doi.org\/10.1007\/s11739-019-02101-8","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,10]]},"assertion":[{"value":"10 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted according to the Declaration of Helsinki and approved by the ethics committee of the Verona University Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of human and animal rights"}},{"value":"All the patients gave written informed consent to the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}